Nottingham, United Kingdom

Kevin Joly


 

Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 84(Granted Patents)


Company Filing History:


Years Active: 2012-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kevin Joly: Innovator in Respiratory Formulations

Introduction

Kevin Joly is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of respiratory formulations, holding a total of 3 patents. His work focuses on developing innovative solutions for treating respiratory disorders.

Latest Patents

Kevin Joly's latest patents include advancements in respiratory formulations and compounds designed for therapeutic use. These inventions relate to formulations that comprise a specific compound of formula (I). They are aimed at treating inflammatory diseases and respiratory disorders, particularly those that are inflammatory mediated or virally mediated, such as asthma and COPD. Additionally, his inventions address the treatment or prevention of viral infections, including those caused by influenza virus, rhinovirus, or RSV. The patents also extend to certain novel compounds of formula (I).

Career Highlights

Throughout his career, Kevin has been associated with Respivert Limited, where he has played a crucial role in advancing respiratory health solutions. His expertise and innovative approach have positioned him as a key figure in the development of effective treatments for respiratory conditions.

Collaborations

Kevin Joly has collaborated with notable colleagues, including Peter John Murray and Jonathan Gareth Williams. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking advancements in respiratory formulations.

Conclusion

Kevin Joly's contributions to respiratory formulations demonstrate his commitment to improving health outcomes for individuals with respiratory disorders. His innovative patents and collaborative efforts continue to shape the future of respiratory treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…